T4 DNA Polymerase-Proofread DNA Binding Identifier for Sensitive Homogeneous Immunoassays
Analytical Chemistry · 29.04.2025 · 97 (16) · 8890-8899
DOI: 10.1021/acs.analchem.5c00093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 15.04.2025. Verfasst von Yujie Guang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China. Hauptthemen laut MEDLINE: DNA-Directed DNA Polymerase, Aptamers, Nucleotide, DNA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Chongqing Science and Technology Commission, National Natural Science Foundation of China, Foundation for Innovative Research Groups of Chongqing.
Abstract (Originalsprache)
Aptamer-based homogeneous immunoassays exhibit considerable potential in the domains of bioanalysis and biodiagnosis owing to their universality in analyzing both proteins and small molecules as well as their compatibility with nucleic acid amplification technologies. Nevertheless, the substantial signal leakage by nonspecific aptamer allostery poses a challenge to enhancing sensitivity further. Herein, we reported a T4 DNA polymerase-proofread DNA binding identifier (ReID). This strategy could harness the dual-enzymatic activity of T4 DNA polymerase to eliminate the leaked signal, thereby efficiently integrating target-induced aptamer allostery with subsequent polymerase chain reaction signal amplification. Moreover, we explored the regulation mechanism of dNTPs concentration on the dual-enzymatic activity of the T4 DNA polymerase. As a result, this strategy achieved an ultrasensitive protein detection limit of 8 fg/mL, validating the effectiveness of this proofreading approach. The universality was further confirmed by highly sensitive detection of small molecules. The exploration of ReID represents a significant advancement in the sensitivity and universality of immunoassays, even demonstrating the potential for multiple proteomic assays, offering a novel perspective for the development of high-performance homogeneous immunoassays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
- The Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
- Zybio Inc, Chongqing 400082, P. R. China.
- Western Institute of Digital-Intelligent Medicine, Chongqing 401329, P. R. China.
Förderung
- Chongqing Science and Technology Commission
- National Natural Science Foundation of China
- Foundation for Innovative Research Groups of Chongqing
- China Postdoctoral Science Foundation
- Chongqing Municipal Education Commission
Zitieren
APA
Guang, Y., Tang, M., Song, Q., Huang, Y., Su, L., Wang, J., Dai, Y., Liu, Z., Cheng, W., & Yang, T. (2025). T4 DNA Polymerase-Proofread DNA Binding Identifier for Sensitive Homogeneous Immunoassays. Analytical Chemistry, 97(16), 8890-8899. https://doi.org/10.1021/acs.analchem.5c00093
Vancouver
Guang Y, Tang M, Song Q, Huang Y, Su L, Wang J, et al. T4 DNA Polymerase-Proofread DNA Binding Identifier for Sensitive Homogeneous Immunoassays. Analytical Chemistry. 2025;97(16):8890-8899. doi:10.1021/acs.analchem.5c00093
BibTeX
@article{Guang2025,
author = {Guang, Yujie and Tang, Man and Song, Qitao and Huang, Yuanyuan and Su, Long and Wang, Jing and Dai, Yulian and Liu, Zhangling and Cheng, Wei and Yang, Tiantian},
title = {T4 DNA Polymerase-Proofread DNA Binding Identifier for Sensitive Homogeneous Immunoassays},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {16},
pages = {8890--8899},
doi = {10.1021/acs.analchem.5c00093}
}
EUVIMED